Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 6, 2013, Pages 904-908

  Messer, Jamie C ^a   Terrell, John D ^b   Herman, Michael P ^c   Ng, Casey K ^c   Scherr, Douglas S ^c   Scoll, Benjamin ^d   Boorjian, Stephen A ^d   Uzzo, Robert G ^d   Wille, Mark ^e   Eggener, Scott E ^e   Lucas, Steven M ^b   Lotan, Yair ^b   Shariat, Shahrokh F ^c   Raman, Jay D ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; HYDRONEPHROSIS; KIDNEY PELVIS TUMOR; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR LOCALIZATION; URETER TUMOR;

COMPUTED TOMOGRAPHY (CT); INTRAVENOUS PYELOGRAM (IVP); MAGNETIC RESONANCE IMAGING (MRI); RENAL PELVIS; RENAL ULTRASONOGRAPHY (RUS); TRANSITIONAL CELL CARCINOMA (TCC); URETER;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; HYDRONEPHROSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEPHRECTOMY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; URETER; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 84880701893     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.07.011     Document Type: Article

References (19)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59: 225-249.
2. Margulis V., Shariat S.F., Matin S.F., et al. Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009, 115: 1224-1233.
3. Soderdahl D.W., Fabrizio M.D., Rahman N.U., et al. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol 2005, 23: 114-212.
4. Sowter S.J., Ilie C.P., Efthimiou I., et al. Endourologic management of patients with upper-tract transitional-cell carcinoma: Long-term follow-up in a single center. J Endourol 2007, 21: 1005-1009.
5. Matin S.F., Margulis V., Kamat A., et al. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract urothelial carcinoma. Cancer 2010, 116: 3127-3134.
6. Canter D., Guzzo T.J., Resnick M.J., et al. Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle invasive transitional cell carcinoma with radical cystectomy. Urology 2008, 72: 379-383.
7. Chapman D.M., Pohar K.S., Gong M.C., et al. Preoperative hydronephrosis as an indicator of survival after radical cystectomy. Urol Oncol 2009, 27: 491-495.
8. Stimson C.J., Cookson M.S., Barocas D.A., et al. Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. J Urol 2010, 183: 1732-1737.
9. McCarron J.P., Mills C., Vaughn E.D. Tumors of the Renal Pelvis and Ureter: Current Concepts and Management. Semin Urol 1983, 1: 75-81.
10. Chung H.J., Chen K.K., Lin A.T., et al. Is renal function at the tumor side a prognostic factor in ureteral transitional cell carcinoma. Urol Int 1997, 59: 166-169.
11. Cho K.S., Hong S.J., Cho N.H., et al. Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma. Urology 2007, 270: 662-666.
12. Ng C.K., Shariat S.F., Lucas S.M., et al. Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper tract urothelial carcinoma?. Urol Oncol 2011, 29: 27-32.
13. Chen G.L., Bagley D.H. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol 2000, 164: 1173-1176.
14. Hall M.C., Womack S., Sagalowsky A.I., et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: 30-Year experience in 252 patients. Urology 1998, 52: 594-601.
15. Hellenthal N.J., Shariat S.F., Margulis V., et al. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: Results from the upper tract urothelial carcinoma collaboration. J Urol 2009, 182: 900-906.
16. Keeley F.X., Kulp D.A., Bibbo M., et al. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 1997, 157: 33-37.
17. Guarnizo E., Pavlovich C.P., Seiba M., et al. Ureteroscopic biopsy of upper tract urothelial carcinoma: Improved diagnostic accuracy and histopathologic considerations using a multi-biopsy approach. J Urol 2000, 163: 52-55.
18. Messer J., Shariat S.F., Brien J.C., et al. Urinary cytology has a poor performance for predicting invasive or high grade upper-tract urothelial carcinoma. BJU Int 2011, [Epub ahead of print].
19. Brien J., Shariat S.F., Herman M.P., et al. Preoperative Hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 2010, 184: 69-73.